EUVIMEDEUVIMED entdecken
Crossref

Antibody Response to Pneumococcal, Influenza, and COVID-19 Vaccination in Patients With Multiple Myeloma

Pranjal Singh, Charanpreet Singh, Kamaljeet Kamaljeet, Vijayalakshmi Aravindan Arun, Radha Kanta Ratho, Archana Angrup, Arihant Jain, Sreejesh Sreedharanunni, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra

Clinical Lymphoma Myeloma and Leukemia · 2025

DOI: 10.1016/j.clml.2025.02.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Pranjal Singh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Multiple Myeloma, Pneumococcal Vaccines, Influenza Vaccines, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPneumococcal VaccinesInfluenza VaccinesCOVID-19COVID-19 VaccinesInfluenza, HumanAntibodies, ViralAntibody FormationHumansMaleFemaleMiddle AgedAgedProspective StudiesSARS-CoV-2VaccinationAged, 80 and overAdultPneumococcal Infections

Stichwörter der Autor:innen

Immune paresisImmunocompromisedInfectionMultiple myelomaVaccine

Substanzen

Pneumococcal VaccinesInfluenza VaccinesCOVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: hematpgi@gmail.com.

Zitieren

APA

Singh, P., Singh, C., Kamaljeet, K., Arun, V. A., Ratho, R. K., Angrup, A., Jain, A., Sreedharanunni, S., Prakash, G., Khadwal, A., & Malhotra, P. (2025). Antibody Response to Pneumococcal, Influenza, and COVID-19 Vaccination in Patients With Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.02.006

Vancouver

Singh P, Singh C, Kamaljeet K, Arun VA, Ratho RK, Angrup A, et al. Antibody Response to Pneumococcal, Influenza, and COVID-19 Vaccination in Patients With Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2025.02.006

BibTeX
@article{Singh2025,
  author = {Singh, Pranjal and Singh, Charanpreet and Kamaljeet, Kamaljeet and Arun, Vijayalakshmi Aravindan and Ratho, Radha Kanta and Angrup, Archana and Jain, Arihant and Sreedharanunni, Sreejesh and Prakash, Gaurav and Khadwal, Alka and Malhotra, Pankaj},
  title = {Antibody Response to Pneumococcal, Influenza, and COVID-19 Vaccination in Patients With Multiple Myeloma},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2025},
  doi = {10.1016/j.clml.2025.02.006}
}
Kostenlos starten →